Your are here: Home // Posts Tagged With fda

Growing Safety Concerns about Diabetes Drugs

Growing Safety Concerns about Diabetes Drugs & its Unethical Trials Dr. David Juurlink, the chief of clinical pharmacology and toxicology at Sunnybrook Health Sciences Center (in Toronto) has urgred FDA to halt the continuing drug trial for diabetes drug rosiglitazone (aka Avandia) as resaerch has proved it as a factor enhancing the proability of cardiovascular diseases in users 30% more than its... 

Avandia Leads Heart Attack

Avandia Leads Heart Attack
Avandia Leads Heart Attack Diabetes is a dangerous disease and need the best and intensive medicine. Because this dangerous disease can lead patients to get chronic complications if there is no accurate and intensive medical treatment. Have you ever heard about Avandia? At the first time, this medicine is trusted to heal diabetes. However, nowadays, many researchers such as Canadian researchers and... 

FDA Decision to Reconsider Bydureon

FDA’s Decision to Reconsider ‘Bydureon’ – Another Chance for Diabetes Drug After rejecting the approval application of diabetes drug ‘Bydureon’ in March 2010, FDA (Food and Drug Administration) has now decided to reconsider it, Alkermes Inc reported. This thing will provide ‘Bydureon’ another chance of getting approved by FDA to be used as reliable and useful drug in treating distressing... 

Diabetes Drug Byetta Rejected by FDA

Diabetes Drug Byetta Rejected by FDA
The U.S. FDA  denied approval of the diabetes drug Byetta, sold by Amylin Pharmaceuticals & Eli Lilly, the FDA reasoned in a letter sent to the 2 companies - more information is needed about the drug’s product label, risk-management plan and manufacturing process. Amylin responded right away and it aims to submit its response to the FDA “in the next few weeks.” Despite... 
Get Adobe Flash playerPlugin by wpburn.com wordpress themes
Copyright © 2010 Diabetes Insider. All rights reserved.